Life Sciences Tools and Services
Company Overview of ForteBio, Inc.
ForteBio, Inc. develops analytical systems to accelerate biotherapeutic drug discovery and development for biopharmaceutical companies worldwide. The company offers Octet System, a platform that includes instruments, biosensors, reagents, and assay kits for the analysis of biomolecular interactions in 96- and 384-well microplates; BLItz System, a personal protein analysis system for individual researchers; biosensors and assay kits; and anti-Chinese hamster ovary host cell proteins detection kits. Its systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics, and concentration; and allow scientists in life science, pharmaceutical,...
Menlo Science & Technology Park
1360 Willow Road
Menlo Park, CA 94025
Founded in 2001
Key Executives for ForteBio, Inc.
Chief Executive Officer, President and Director
Vice President of Product Development & Operations and General Manager
Vice President of China Operations
Vice President of Marketing
Compensation as of Fiscal Year 2016.
ForteBio, Inc. Key Developments
Pall ForteBio LLC Launches Octet K2 System
Mar 31 15
Pall ForteBio LLC announced the launch of the Octet K2 system, a new entry point into the Octet line of label-free interaction analysis systems. Available in Asia and Europe, the Octet K2 system offers high-performance, budget-friendly kinetic characterization of antibody, protein, and small molecule binding interactions. Using Pall ForteBio’s Bio-Layer Interferometry (BLI) technology, the systems in the Octet family offer a fluidics-free alternative to surface plasmon resonance (SPR) with a variety of off-the-shelf Dip and Read™ biosensors for more rapid assay development and optimization. The Octet K2 system increases accessibility to BLI in a low-throughput, 2-channel instrument that provides exquisite binding affinity data, even for molecules down to 150 daltons in size.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries